
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease
Author(s) -
Silvano Dragonieri,
Vitaliano Nicola Quaranta,
Pierluigi Carratù,
Donato Lacedonia,
Giovanna Elisiana Carpagnano,
A.D. Milano,
Giuseppina D’Alba,
Teresa Ranieri,
Maria Pia Foschino Barbaro,
Onofrio Resta
Publication year - 2016
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.189000
Subject(s) - medicine , bode index , roflumilast , copd , body mass index , exacerbation , systemic inflammation , vital capacity , pulmonary rehabilitation , lung , inflammation , diffusing capacity , lung function